Rituximab Shows Long-Term Benefits in Follicular Lymphoma ...Middle East

Medscape - News
Rituximab Shows Long-Term Benefits in Follicular Lymphoma
Long-term results of a phase 3 trial show that early rituximab monotherapy significantly delays the need for new treatment in patients with asymptomatic, low tumour burden follicular lymphoma. Medscape News UK

Hence then, the article about rituximab shows long term benefits in follicular lymphoma was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Rituximab Shows Long-Term Benefits in Follicular Lymphoma )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News